The Effect of Prior Androgen Synthesis Inhibition on Outcomes of Subsequent Therapy with Docetaxel in Patients with Metastatic Castrate Resistant Prostate Cancer: Results from a Retrospective Analysis of a Randomized Phase 3 Clinical Trial (CALGB 90401) (Alliance)
      QxMD      Google Scholar   
Citation:
Cancer vol 119 (20) 3636-3643
Year:
2013
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
3
Parents:
760  
Children:
None
Program:
OGC
Primary Committee:
GU
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, CA04457, CA11789, CA77406, CA16359, CA47577, CA35113, CA32291, CA29165, CA41287, U10 CA021115, U10 CA031946, CA77651, U10 CA033601, CA59518, CA60138, CA45389, CA13650, CA37447, CA45808, CA35279, CA35421, CA86726, CA16450, CA77440, CA45564, CA7577, CA04326, CA08025, CA74811, CA21060, CA5808, CA47559, CA114558-02, CA45418, CA77658, CA77298, CA114558, CA31983, CA31946, CA16116, CA07968  
Corr. Author:
 
Authors:
                         
Primary Study
CALGB-90401
Secondary Studies:
Phases:
3
Keywords:
Article